Staff Profile

I am a Senior Research Associate in the Health Economics Group within the Population Health Sciences Institute and an NIHR Applied Research Collaboration (ARC) Fellow in the 'Enabling Methodologies' Theme. 

I previously worked part-time with Prof Clare Bambra in the Social Determinants of Health team (2017-2019). 

I was awarded my PhD in January 2018. My thesis was entitled 'Exploring Inequalities in Child Cognitive Ability, Psychological Well-Being and Adolescent Risky Health Behaviours', and was supervised by Dr Heather Brown, Dr Jing Shen and Prof John Wildman.

I have published papers in high impact journals such as Value in Health, Journal of Epidemiology & Community Health, Pharmacoeconomics and Cochrane Database of Systematic Reviews, and contributed to reports for NHS England, NIHR, NICE and NHSA. 

My current research interests include:

• Measuring and valuing health-related quality of life 
• Preference elicitation methods
• Socioeconomic Inequalities in Health

Areas of expertise

• Health Economics
• Health Inequalities
• Applied Econometrics

Qualifications

• Doctor of Philosophy, Newcastle University (2013-2018)
• MSc Health Economics, University of York (2012-2013)
• BA Economics, Newcastle University (2008-2011)

For a full list of publications please see my Google Scholar: https://goo.gl/onc7mY

I am currently working on a number of different research projects. Examples include:

REINFORCE

A real-world, in-situ, evaluation of the introduction and scale-up of robot-assisted surgical services in the NHS

CHESS

Investigating the clinical and cost-effectiveness of CHildren’s Early Self-care Support in children with neurodisability: the CHESS cluster randomised controlled trial

PLACES

Promoting Local Access to Children’s Early language and communication Support

Adult Autism Health Checks

Design and initial evaluation of an autism-specific health check for use with autistic adults in NHS Primary Care

I have previously worked on projects related to the NHS 111 service, health and productivity, inequalities in infant mortality, end of life care for people with dementia, the HRQoL of children with obesity, laser therapy in head and neck cancer and different treatment strategies for brain cancer. 

I also regularly work on technology appraisals for both the Newcastle Technology Assessment (TAR) Group and the Newcastle External Assessment Group (EAG) and am an advisor for the Newcastle Research Support Service (RSS) Hub.

Funding

An evaluation Tier 3 specialist weight management services on patient outcomes and experiences with health economic analysis: a mixed methods study design – 2024 NENC Integrated Care Board (Gateshead) £154,430. Co-investigator (PI Dr Mackenzie Fong)

PLACES: Promoting Local Access to Children’s Early language and communication Support - 2023 NIHR Health and Social Care Delivery Programme (£1,197,493). Co-investigator (PIs Prof Lindsay Pennington & Prof Cristina McKean)

Investigating the clinical and cost-effectiveness of CHildren’s Early Self-care Support in children with neurodisability: the CHESS cluster randomised controlled trial - 2023 NIHR Health Technology Assessment (£2,389,056). Co-investigator (PI Prof Niina Kolehmainen)

REINFORCE: A real-world, in-situ, evaluation of the introduction and scale-up of robot-assisted surgical services in the NHS - 2023 NIHR Health and Social Care Delivery Programme (£1,397,638). Co-investigator (PIs Prof David Beard & Prof Marion Campbell)

Meeting Social Welfare Legal Needs in End of Life Care: Co-creation of a System-wide Research Partnership – 2022 Health and Social Care Delivery Programme (£70,581). Co-investigator (PI Dr Colette Hawkins)

Pilot valuation study for the WAItE in the Australian population – 2021 Newcastle University International Partnership Seed Fund (£9,668). Lead investigator

Design and initial evaluation of an autism-specific health check for use with autistic adults in NHS Primary Care - 2020 Autistica/NHS England (£454,246). Co-investigator (PIs Prof Jeremy Parr & Dr Barry Ingham)

MapMe2: Can embedding the MapMe intervention, a tool to improve parental acknowledgement and understanding of childhood overweight and obesity, in the National Child Measurement Programme lead to improved child weight outcomes at one year? – NIHR Public Health Research (£1,774,489). Co-investigator (PI Prof Ashley Adamson)

I am the module leader for the 'Practical Health Economics for Cancer' e-module (ONC8028) on the MSc Oncology and Palliative Care. 

I currently co-supervise two PhD students:

Will King: How should we measure and value changes in child quality of life for use in economic evaluation, in the context of obesity management?

Muath Alrashed: Identification and validation of a classification system for a malocclusion-specific preference-based measure of oral health-related quality of life.

I also regularly supervise BSc and MSc dissertations.

• Articles

  • Robinson T, Hill S, Orozco-Leal G, Kernohan A, King W, Oluboyede Y. Valuing selected WAItE health states using the Time Trade-Off methodology: findings from an online interviewer-assisted remote survey. Journal of Patient-Reported Outcomes 2024, 8(1).
  • Funuyet-Salas J, Martin-Rodriguez A, Perez-San-Gregorio MA, Vale L, Robinson T, Anstee QM, Romero-Gomez M. Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United Kingdom. PLoS ONE 2024, 19(5), e0300362.
  • Orozco Leal G, Johnson EE, Hosseinijebeli S, Robinson T, Homer T, Eastaugh C, Richmond C, Tanner L, Meader N, Kenny R, Wallace SA, Rice S. Considerations for the cure assumption in a NICE Single Technology Appraisal of nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small cell lung cancer: Evidence Assessment Group perspective. PharmacoEconomics 2024, 42, 133-136.
  • Orozco leal G, Armstrong N, Kernohan A, Ahmadu C, Coughlan D, McDermott K, Duffy S, O'Meara S, Robinson T, Vale L, Kleijnen J. Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics 2023, 41(7), 741-750.
  • Nugent M, Bryant V, Butcher C, Fisher H, Gill S, Goranova R, Hiu S, Lindley L, O'Hara J, Oluboyede Y, Patterson J, Rapley T, Robinson T, Rousseau N, Ryan V, Shanmugasundaram R, Sharp L, Smith Whelan R, Stocken DD, Ternent L, Wilson JA, Walker J. Photobiomodulation in the management of oral mucositis for adult head and neck cancer patients receiving irradiation: the LiTEFORM RCT. Health Technology Assessment 2022, 26(46).
  • Robinson T, Oluboyede Y, Vale L, Olariu E. Differences in health-related quality of life between the Roma community and the general population in Romania. Journal of Patient-Reported Outcomes 2022, 6(1), 127.
  • McBain C, Lawrie T, Rogozinska E, Kernohan A, Robinson T, Jefferies T. Treatment options for progression or recurrence of glioblastoma: a network meta-analysis. Cochrane Database of Systematic Reviews 2021, (1), CD013579.
  • Hanna C, Lawrie T, Rogozinska E, Kernohan A, Jefferies S, Bulbeck H, Ali U, Robinson T, Grant R. Treatment of newly diagnosed glioblastoma in the elderly: a network meta‐analysis. Cochrane Database of Systematic Reviews 2020, (3).
  • Grant R, Dowswell T, Tomlinson E, Brennan PM, Walter FM, Ben-Shlomo Y, Hunt DW, Bulbeck H, Kernohan A, Robinson T, Lawrie TA. Interventions to reduce the time to diagnosis of brain tumours. Cochrane Database of Systematic Reviews 2020, (9), CD013564.
  • Thomson K, Berry R, Robinson T, Brown H, Bambra C, Todd A. An examination of trends in antibiotic prescribing in primary care and the association with area-level deprivation in England. BMC Public Health 2020, 20, 1148.
  • Oluboyede Y, Robinson T. Measuring Weight Specific Quality of Life in Adolescents: An Examination of the Concurrent Validity and Test Re-Test Reliability of the WAItE. Value in Health 2019, 22(3), 348-354.
  • Robinson T, Brown H, Norman P, Barr B, Fraser L, Bambra C. Investigating the impact of New Labour's English health inequalities strategy on geographical inequalities in infant mortality: a time trend analysis. Journal of Epidemiology and Community Health 2019, 73, 564-568.
  • Robinson T, Oluboyede Y. Estimating CHU-9D Utility Scores from the WAItE: A Mapping Algorithm for Economic Evaluation. Value in Health 2019, 22(2), 239-246.

• Reports

  • Robinson L, Poole M, McLellan E, Lee R, Amador S, Bhattarai N, Bryant A, Coe D, Corbett A, Exley C, Goodman C, Gotts Z, Harrison-Dening K, Hill S, Howel D, Hrisos S, Hughes J, Kernohan A, Macdonald A, Mason H, Massey C, Neves S, Paes P, Rennie K, Rice S, Robinson T, Sampson E, Tucker S, Tzelis D, Vale L, Bamford C. Supporting good quality, community-based end-of-life care for people living with dementia: the SEED research programme including feasibility RCT. National Institute for Health Research, 2020. 8.
  • Bambra C, Munford L, Brown H, Wilding A, Robinson T, Holland P, Barr B, Hill H, Regan M, Rice N, Sutton M. Health for Wealth: Building a Healthier Northern Powerhouse for UK Productivity. Northern Health Sciences Alliance, 2018.
  • Stobbart L, O'Donnell A, Akor W, Albani V, Brown H, Craig D, Fattakhova G, Harrison S, Kaner E, Kirkman S, Lally J, Little M, Mott D, Rice S, Robinson T, Scott J, Shaw C, Spencer L, Tandogdu Z, Vaittinen A, Watson N, Whalley E, Vale L. Phase Two of the NHS 111 Learning and Development Pilot Programme: Final Report. NHS England, 2015.

• Reviews

  • Sagoo GS, Robinson T, Coughlan D, Meader N, Rice S, Vale L. Evaluating high-cost technologies–no need to throw the baby out with the bathwater. Expert Review of Pharmacoeconomics and Outcomes Research 2023, 23(10), 1177-1183.
  • McAleenan A, Kelly C, Spiga F, Kernohan A, Cheng H-Y, Dawson S, Schmidt L, Robinson T, Brandner S, Faulkner CL, Wragg C, Jefferies S, Howell A, Vale L, Higgins JPT, Kurian KM. Prognostic value of test(s) for O6-methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide. Cochrane Database of Systematic Reviews 2021, 2021(3), : CD013316.